首页 > 最新文献

Journal of the Formosan Medical Association最新文献

英文 中文
Resurgence of acute hepatitis A outbreak: Lessons learned from past success and recurrence. 急性甲型肝炎再次爆发:从过去的成功和复发中吸取的教训。
IF 2.5 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-12-12 DOI: 10.1016/j.jfma.2025.12.019
Kuan-Yin Lin, Guan-Jhou Chen, Chien-Ching Hung
{"title":"Resurgence of acute hepatitis A outbreak: Lessons learned from past success and recurrence.","authors":"Kuan-Yin Lin, Guan-Jhou Chen, Chien-Ching Hung","doi":"10.1016/j.jfma.2025.12.019","DOIUrl":"https://doi.org/10.1016/j.jfma.2025.12.019","url":null,"abstract":"","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145751734","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on "Integrating traditional Chinese Medicine reduced the risk of hip fracture in patients with dementia": Unraveling the causal pathway from TCM to fracture prevention. “中西医结合降低痴呆患者髋部骨折风险”点评:揭示中医预防骨折的因果通路
IF 2.5 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-12-12 DOI: 10.1016/j.jfma.2025.12.018
Zhaoxin Wu, Kai Wu
{"title":"Comment on \"Integrating traditional Chinese Medicine reduced the risk of hip fracture in patients with dementia\": Unraveling the causal pathway from TCM to fracture prevention.","authors":"Zhaoxin Wu, Kai Wu","doi":"10.1016/j.jfma.2025.12.018","DOIUrl":"https://doi.org/10.1016/j.jfma.2025.12.018","url":null,"abstract":"","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145751731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to: Pembrolizumab in advanced endometrial cancer: Dosing equivalence and molecular insights from an Asian cohort. 对Pembrolizumab治疗晚期子宫内膜癌的反应:来自亚洲队列的剂量等效性和分子见解
IF 2.5 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-12-12 DOI: 10.1016/j.jfma.2025.12.022
Kuang-Yen Lee, Ying-Cheng Chiang, Bor-Ching Sheu, Wen-Chun Chang
{"title":"Response to: Pembrolizumab in advanced endometrial cancer: Dosing equivalence and molecular insights from an Asian cohort.","authors":"Kuang-Yen Lee, Ying-Cheng Chiang, Bor-Ching Sheu, Wen-Chun Chang","doi":"10.1016/j.jfma.2025.12.022","DOIUrl":"https://doi.org/10.1016/j.jfma.2025.12.022","url":null,"abstract":"","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145751740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to Comments on "Comparison of the clinicoradiological features and outcomes of lymphoepithelioma-like cholangiocarcinoma and conventional intrahepatic cholangiocarcinoma: A propensity score matching analysis". 对《淋巴上皮瘤样胆管癌与常规肝内胆管癌的临床放射学特征及预后比较:倾向评分匹配分析》评论的回应。
IF 2.5 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-12-12 DOI: 10.1016/j.jfma.2025.12.020
Yan-Chih Peng, Jia-Huei Tsai, Jia-Horng Kao, Kao-Lang Liu
{"title":"Response to Comments on \"Comparison of the clinicoradiological features and outcomes of lymphoepithelioma-like cholangiocarcinoma and conventional intrahepatic cholangiocarcinoma: A propensity score matching analysis\".","authors":"Yan-Chih Peng, Jia-Huei Tsai, Jia-Horng Kao, Kao-Lang Liu","doi":"10.1016/j.jfma.2025.12.020","DOIUrl":"https://doi.org/10.1016/j.jfma.2025.12.020","url":null,"abstract":"","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145751753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to the comment on "Improved cost-effectiveness for management of chronic heart failure by combined home-based intervention with clinical nursing specialists (JFMA-D-25-01320)". 对“通过临床护理专家联合家庭干预提高慢性心力衰竭管理的成本效益(JFMA-D-25-01320)”评论的回应。
IF 2.5 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-12-11 DOI: 10.1016/j.jfma.2025.12.021
Chi-Sheng Hung, Yi-Lwun Ho, Ming-Fong Chen
{"title":"Response to the comment on \"Improved cost-effectiveness for management of chronic heart failure by combined home-based intervention with clinical nursing specialists (JFMA-D-25-01320)\".","authors":"Chi-Sheng Hung, Yi-Lwun Ho, Ming-Fong Chen","doi":"10.1016/j.jfma.2025.12.021","DOIUrl":"https://doi.org/10.1016/j.jfma.2025.12.021","url":null,"abstract":"","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145743109","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to "Comment on 'Risk of colon polyps and colorectal cancer in primary biliary cholangitis, a population-based retrospective cohort study in Taiwan'". 回复“台湾原发性胆管炎患者发生结肠息肉及结直肠癌风险的回顾性队列研究”评论。
IF 2.5 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-12-11 DOI: 10.1016/j.jfma.2025.12.015
Pei-Tzu Chen, Hsuan-Wei Chen
{"title":"Reply to \"Comment on 'Risk of colon polyps and colorectal cancer in primary biliary cholangitis, a population-based retrospective cohort study in Taiwan'\".","authors":"Pei-Tzu Chen, Hsuan-Wei Chen","doi":"10.1016/j.jfma.2025.12.015","DOIUrl":"https://doi.org/10.1016/j.jfma.2025.12.015","url":null,"abstract":"","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145743131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on "Risk of colon polyps and colorectal cancer in primary biliary cholangitis, a population-based retrospective cohort study in Taiwan". 台湾原发性胆管炎患者发生结肠息肉和结直肠癌的风险:一项基于人群的回顾性队列研究。
IF 2.5 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-12-11 DOI: 10.1016/j.jfma.2025.12.016
MeiLing Jin
{"title":"Comment on \"Risk of colon polyps and colorectal cancer in primary biliary cholangitis, a population-based retrospective cohort study in Taiwan\".","authors":"MeiLing Jin","doi":"10.1016/j.jfma.2025.12.016","DOIUrl":"https://doi.org/10.1016/j.jfma.2025.12.016","url":null,"abstract":"","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145743146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on "The toxicity of hybrid techniques combining hypofractionated whole breast radiotherapy with concomitant tumor bed boost in patients with breast cancer". 评议“低分割全乳放疗联合肿瘤床强化混合技术对乳腺癌患者的毒性”。
IF 2.5 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-12-10 DOI: 10.1016/j.jfma.2025.12.009
Wanting Xu, Yinping Lao, Qiping Wu, Xiaoling Huang
{"title":"Comment on \"The toxicity of hybrid techniques combining hypofractionated whole breast radiotherapy with concomitant tumor bed boost in patients with breast cancer\".","authors":"Wanting Xu, Yinping Lao, Qiping Wu, Xiaoling Huang","doi":"10.1016/j.jfma.2025.12.009","DOIUrl":"https://doi.org/10.1016/j.jfma.2025.12.009","url":null,"abstract":"","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145743074","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Validating pelvic stone angle as a substitute for infundibulopelvic angle in RIRS outcome prediction. 验证盆腔结石角在RIRS预后预测中的替代作用。
IF 2.5 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-12-10 DOI: 10.1016/j.jfma.2025.12.011
J C Elises, D Parikesit, M Zogan, N Aljameel, M Alharthi, S Y Cho, H Y Lee

Introduction: The infundibulopelvic angle (IPA) is a well-established predictor of stone-free rate (SFR) following retrograde intrarenal surgery (RIRS), particularly for lower pole stones. The pelvic stone angle (PSA) has been proposed as a simpler alternative. This study aimed to externally validate PSA and assess its utility relative to IPA and other scoring systems.

Methods: We retrospectively reviewed 110 patients with lower pole renal stones who underwent RIRS between January 2022 and January 2024 at a single center. PSA, IPA, RIRS score, and Resorlu-Unsal Stone Score (RUSS) were calculated independently by five urologists, and averaged values were analyzed. Stone-free status was defined as no residual fragments >2 mm on CT within three months. Predictive performance was assessed using logistic regression and ROC analysis.

Results: Among 110 patients, 58.2 % achieved stone-free status. Although PSA was not statistically different between stone-free and non-stone-free groups, the R.I.R.S. scoring system incorporating PSA (AUC = 0.7242) showed comparable predictive performance to the IPA-based model (AUC = 0.7021, p = 1.000). Both PSA and IPA were significantly associated with SFR in multivariate analysis. Cronbach's α values for PSA and IPA exceeded 0.95, indicating high interobserver reliability.

Conclusions: This study confirms that PSA is a viable substitute for IPA in predicting SFR after RIRS, with comparable accuracy and reliability. As an external validation of previous findings, our results support the broader adoption of PSA in clinical scoring systems. Future studies should further investigate PSA's role in newer surgical settings, including suction-assisted RIRS.

导说:骨盆底管角(IPA)是逆行肾内手术(RIRS)后无结石率(SFR)的一个公认的预测指标,特别是对于下极结石。盆腔结石角(PSA)被认为是一种更简单的替代方法。本研究旨在外部验证PSA,并评估其相对于IPA和其他评分系统的效用。方法:我们回顾性分析了2022年1月至2024年1月在单一中心接受RIRS治疗的110例下极肾结石患者。由5名泌尿科医师独立计算PSA、IPA、RIRS评分和reslu - unsal结石评分(RUSS)并分析平均值。无结石状态定义为3个月内CT上无残留碎片bb0 2mm。采用logistic回归和ROC分析评估预测性能。结果:110例患者中,58.2%达到无结石状态。虽然PSA在无结石组和非无结石组之间没有统计学差异,但纳入PSA的R.I.R.S.评分系统(AUC = 0.7242)的预测性能与基于ipa的模型(AUC = 0.7021, p = 1.000)相当。在多变量分析中,PSA和IPA与SFR均有显著相关性。PSA和IPA的Cronbach’s α值超过0.95,表明观察者间信度高。结论:本研究证实PSA是预测RIRS术后SFR的可行替代IPA,具有相当的准确性和可靠性。作为先前研究结果的外部验证,我们的结果支持PSA在临床评分系统中的广泛采用。未来的研究应进一步研究PSA在新手术环境中的作用,包括吸痰辅助RIRS。
{"title":"Validating pelvic stone angle as a substitute for infundibulopelvic angle in RIRS outcome prediction.","authors":"J C Elises, D Parikesit, M Zogan, N Aljameel, M Alharthi, S Y Cho, H Y Lee","doi":"10.1016/j.jfma.2025.12.011","DOIUrl":"https://doi.org/10.1016/j.jfma.2025.12.011","url":null,"abstract":"<p><strong>Introduction: </strong>The infundibulopelvic angle (IPA) is a well-established predictor of stone-free rate (SFR) following retrograde intrarenal surgery (RIRS), particularly for lower pole stones. The pelvic stone angle (PSA) has been proposed as a simpler alternative. This study aimed to externally validate PSA and assess its utility relative to IPA and other scoring systems.</p><p><strong>Methods: </strong>We retrospectively reviewed 110 patients with lower pole renal stones who underwent RIRS between January 2022 and January 2024 at a single center. PSA, IPA, RIRS score, and Resorlu-Unsal Stone Score (RUSS) were calculated independently by five urologists, and averaged values were analyzed. Stone-free status was defined as no residual fragments >2 mm on CT within three months. Predictive performance was assessed using logistic regression and ROC analysis.</p><p><strong>Results: </strong>Among 110 patients, 58.2 % achieved stone-free status. Although PSA was not statistically different between stone-free and non-stone-free groups, the R.I.R.S. scoring system incorporating PSA (AUC = 0.7242) showed comparable predictive performance to the IPA-based model (AUC = 0.7021, p = 1.000). Both PSA and IPA were significantly associated with SFR in multivariate analysis. Cronbach's α values for PSA and IPA exceeded 0.95, indicating high interobserver reliability.</p><p><strong>Conclusions: </strong>This study confirms that PSA is a viable substitute for IPA in predicting SFR after RIRS, with comparable accuracy and reliability. As an external validation of previous findings, our results support the broader adoption of PSA in clinical scoring systems. Future studies should further investigate PSA's role in newer surgical settings, including suction-assisted RIRS.</p>","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145743086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Deep brain stimulation and magnetic resonance-guided focused ultrasound in Parkinsonism and related disorders: State-of-the-Art and future prospects. 脑深部刺激和磁共振引导聚焦超声在帕金森病和相关疾病中的应用:现状和未来展望。
IF 2.5 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-12-10 DOI: 10.1016/j.jfma.2025.12.014
Tsung-Lin Lee, Ming-Kuei Lu

Deep brain stimulation (DBS) has been a cornerstone treatment for pharmacologically refractory Parkinson's disease, essential tremor, and dystonia for over three decades. While it offers substantial symptom relief and medication reduction, its invasive nature introduces risks such as surgical complications and hardware-related issues. Magnetic resonance-guided focused ultrasound (MRgFUS) has recently emerged as a non-invasive neuromodulation alternative, providing incisionless lesioning for selected cases, particularly tremor-dominant phenotypes. However, the two modalities differ significantly in terms of mechanism, adaptability, safety profile, and long-term efficacy. This review synthesizes recent developments in DBS and MRgFUS for Parkinsonism and related movement disorders, focusing on clinical efficacy, safety outcomes, and technological innovations. We evaluated the following key areas: adaptive and closed-loop DBS systems, advances in MRgFUS targeting and imaging, long-term outcomes, and the integration of machine learning in DBS personalization. These findings underscore the complementary roles of DBS and MRgFUS, supporting individualized, data-driven treatment approaches and highlighting the need for future large-scale, controlled trials to further optimize therapeutic strategies.

30多年来,深部脑刺激(DBS)一直是治疗药理学上难治性帕金森病、特发性震颤和肌张力障碍的基础疗法。虽然它提供了实质性的症状缓解和药物减少,但其侵入性引入了手术并发症和硬件相关问题等风险。磁共振引导聚焦超声(MRgFUS)最近作为一种非侵入性神经调节替代方法出现,为特定病例提供无切口病变,特别是震颤显性表型。然而,这两种方式在机制、适应性、安全性和长期疗效方面存在显著差异。本文综述了脑起搏器和MRgFUS治疗帕金森病及相关运动障碍的最新进展,重点关注临床疗效、安全性结果和技术创新。我们评估了以下关键领域:自适应和闭环DBS系统,MRgFUS靶向和成像的进展,长期结果,以及DBS个性化中机器学习的集成。这些发现强调了DBS和MRgFUS的互补作用,支持个性化、数据驱动的治疗方法,并强调了未来大规模对照试验进一步优化治疗策略的必要性。
{"title":"Deep brain stimulation and magnetic resonance-guided focused ultrasound in Parkinsonism and related disorders: State-of-the-Art and future prospects.","authors":"Tsung-Lin Lee, Ming-Kuei Lu","doi":"10.1016/j.jfma.2025.12.014","DOIUrl":"https://doi.org/10.1016/j.jfma.2025.12.014","url":null,"abstract":"<p><p>Deep brain stimulation (DBS) has been a cornerstone treatment for pharmacologically refractory Parkinson's disease, essential tremor, and dystonia for over three decades. While it offers substantial symptom relief and medication reduction, its invasive nature introduces risks such as surgical complications and hardware-related issues. Magnetic resonance-guided focused ultrasound (MRgFUS) has recently emerged as a non-invasive neuromodulation alternative, providing incisionless lesioning for selected cases, particularly tremor-dominant phenotypes. However, the two modalities differ significantly in terms of mechanism, adaptability, safety profile, and long-term efficacy. This review synthesizes recent developments in DBS and MRgFUS for Parkinsonism and related movement disorders, focusing on clinical efficacy, safety outcomes, and technological innovations. We evaluated the following key areas: adaptive and closed-loop DBS systems, advances in MRgFUS targeting and imaging, long-term outcomes, and the integration of machine learning in DBS personalization. These findings underscore the complementary roles of DBS and MRgFUS, supporting individualized, data-driven treatment approaches and highlighting the need for future large-scale, controlled trials to further optimize therapeutic strategies.</p>","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145743116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of the Formosan Medical Association
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1